L

Lexington Biosciences Holdings Corp
OTC:LXGTF

Watchlist Manager
Lexington Biosciences Holdings Corp
OTC:LXGTF
Watchlist
Price: 0.0001 USD Market Closed
Market Cap: 38 USD

Operating Margin
Lexington Biosciences Holdings Corp

0%
Current
0%
Average
7.1%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
0%
=
Operating Profit
-170.9k
/
Revenue
0

Operating Margin Across Competitors

No Stocks Found

Lexington Biosciences Holdings Corp
Glance View

Market Cap
38 USD
Industry
N/A

Lexington Biosciences, Inc. is a medical device company, which engages in the research and development of non-diagnostic devices. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2017-06-01. The device measures the function of the endothelium, the cells that line all arteries and are critical to the prevention of atherosclerosis, heart attacks and stroke. The firm is in the final stages of releasing the developed product for clinical studies. The firm's goal is to make HeartSentry accurate, quick, and cost effective so it can become the standard of care for cardiologists, general practitioners, and ultimately patients for first line evaluation of a person’s cardiovascular health.

LXGTF Intrinsic Value
Not Available
L
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
0%
=
Operating Profit
-170.9k
/
Revenue
0
What is the Operating Margin of Lexington Biosciences Holdings Corp?

Based on Lexington Biosciences Holdings Corp's most recent financial statements, the company has Operating Margin of 0%.

Back to Top